Search IPOs
PRAMODINI · NSE · Healthcare Services
Pramodini Medicare IPO listed on 19 Aug 2026 on NSE at ₹120.00, a gain of 1.69% over the issue price of ₹118.00. The IPO was subscribed 3.87x overall.
Pramodini Medicare IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 12 Aug 2026 |
| IPO Close Date | 14 Aug 2026 |
| Basis of Allotment | 17 Aug 2026 |
| Initiation of Refunds | 18 Aug 2026 |
| Credit of Shares to Demat | 18 Aug 2026 |
| Listing Date | 19 Aug 2026 |
Listing day gain
+1.69%
Listed at ₹120 (issue ₹118)
Issue
₹118
Listing
₹120
Current
₹121.65
+3.09% vs issue
Day range
₹114 – ₹125.55
Issue Size
5,851,200 shares
(aggregating up to ₹69.00 Cr)
Issue Price
₹110 – ₹118
Face Value
₹10/share
Market Lot
1,200 shares
Retail Min Investment
₹283,200
Listing At
NSE
Sale Type
both
Fresh Issue
5,014,800 shares
(aggregating up to ₹59 Cr)
Offer for Sale
500,400 shares
(aggregating up to ₹6 Cr)
Reserved for Market Maker
336,000 shares
(aggregating up to ₹4.00 Cr)
Issue Type
book building
Open Date
12 Aug
Close Date
14 Aug
Allotment
17 Aug
Listing
19 Aug
Last updated: 1 month ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 18 Aug 2026 Latest | ₹118 | ₹0 | ₹118 | ₹0 |
0%
|
9:08 PM |
| 18 Aug 2026 | ₹118 | ₹0 | ₹118 | ₹0 |
0%
|
5:14 PM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 14 Aug 2026
| Category | Subscribed (x) | No. of Applications |
|---|---|---|
| QIB | 3.66x | - |
| NII | 4.96x | - |
| bNII (bids above ₹10L) | 5.03x | - |
| sNII (bids below ₹10L) | 4.82x | - |
| Individual Investors | 3.49x | - |
| Total | 3.87x | - |
Showing the latest subscription snapshot.
View full subscription historyChalasani Kuldeep Kumar, Chalasani Kavitha and Sri Ram Medicare Pvt.Ltd. are the promoters of the Company.
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | ₹283,200 |
| Retail (Max) | 2 | 2,400 | ₹283,200 |
| S-HNI (Min) | 3 | 3,600 | ₹424,800 |
| S-HNI (Max) | 7 | 8,400 | ₹991,200 |
| B-HNI (Min) | 8 | 9,600 | ₹1,132,800 |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 2,532,000 (43.28%) |
|
•
Anchor Investor Shares Offered
|
1,360,800 (23.26%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
1,171,200 (20.02%) |
| NII (HNI) Shares Offered | 960,000 (16.41%) |
|
•
bNII > ₹10L
|
639,600 (10.93%) |
|
•
sNII < ₹10L
|
320,400 (5.48%) |
| Individual Investors Shares Offered | 2,023,200 (34.57%) |
| Market Maker Shares Offered | 336,000 (5.74%) |
| Total Shares Offered | 5,851,200 (100.00%) |
Pramodini Medicare Limited was incorporated in 2000 and is based in Vijayawada, Andhra Pradesh. It works in the diagnostic services sector, offering technology-enabled diagnostics across radiology, clinical laboratory, and nuclear medicine.
The company provides radiology services such as MRI, CT scans, X-ray, ultrasound with colour doppler, mammography, DEXA scans, and interventional radiology, along with clinical laboratory testing and nuclear medicine services. It operates through four models: public-private partnerships with government institutions, private partnerships with hospitals, collaborations with public sector undertakings, and standalone private diagnostic centres, serving public and private hospitals, medical colleges, and diagnostic centres across tier I, II, and III cities. As of its DRHP filing, the company operated 15 diagnostic centres across 6 states. Chalasani Kuldeep Kumar and Chalasani Kavitha are among the promoters, along with Sri Ram Medicare Private Limited.
On a restated basis, revenue rose to Rs 38.2 crore in FY25 from Rs 35.2 crore in FY24, while profit rose to Rs 10.04 crore from Rs 5.76 crore over the same period. For the nine months ended December 2025, the company reported revenue of Rs 44.4 crore and profit of Rs 12.5 crore. The IPO is a book-built SME issue of up to 58,51,200 equity shares of face value Rs 10 each, comprising a fresh issue of up to 53,50,800 shares and an offer for sale of up to 5,00,400 shares by the promoter selling shareholders, proposed for listing on NSE Emerge. As per the DRHP, about Rs 45.1 crore from the fresh issue proceeds is proposed to be used for purchase of medical equipment for existing and proposed diagnostic centres, with the balance for general corporate purposes and potential inorganic acquisitions.
Standalone · ₹ in Crores
| Particulars | FY Mar 2024 | FY Mar 2025 | FY Mar 2026 |
|---|---|---|---|
| Total Revenue | 35.79 | 38.55 | 63.38 |
| Profit After Tax (PAT) | 7.14 | 11.14 | 17.38 |
| EBITDA | 15.53 | 20.97 | 30.9 |
| Total Assets | 48.78 | 56.45 | 93.62 |
| Net Worth | 24.75 | 35.77 | 53.15 |
| Reserves & Surplus | 23.46 | 34.49 | 36.46 |
| Total Borrowing | 11.96 | 10.81 | 17.85 |
Revenue & Profit Trend
Key ratios per fiscal period
| Particulars | Mar 2026 |
|---|---|
| RoE Return on Equity Shows how much profit the company makes on the money shareholders have put in. 15% to 20% is healthy in most industries. | 39.08% |
| RoCE Return on Capital Employed Shows the profit earned on all the money used, shareholder funds plus loans. Matters most for factory and infrastructure heavy companies. | 34.66% |
| RoNW Return on Net Worth Shows the profit earned on the company's own net worth. Steady or rising over 3 years is a good sign. | 32.69% |
| PAT Margin Profit After Tax Margin Out of every ₹100 of sales, how much the company keeps after paying all costs, loan interest and tax. | 27.9% |
| EBITDA Margin Earnings Before Interest, Tax, Depreciation and Amortisation Margin Profit from the main business as a share of sales, before loan interest and tax. Compare it with other companies in the same industry. | 49.61% |
| Debt / Equity Debt to Equity How much the company has borrowed against what shareholders own. Above 1x means the loans are bigger than shareholder funds. | 0.34x |
| P/BV Price to Book Value Tells you if the IPO price is above what the company actually owns. 1x to 3x is usually seen as reasonable. | 0.71x |
Issue-level · at the upper price band
| Particulars | Pre-IPO | Post-IPO |
|---|---|---|
| EPS Earnings Per Share Profit the company earns on each share. Post-IPO EPS is usually lower because the issue adds new shares. | ₹10.41 | ₹7.88 |
| P/E Price to Earnings Tells you if the IPO price is fair for what the company earns. Compare it with listed companies in the same sector. | 11.34x | 14.97x |
| Market Cap Market Capitalisation What the whole company is valued at, at the upper price band. Post-IPO counts the new shares the issue creates. | ₹197 Cr | ₹260 Cr |
The basis of allotment for Pramodini Medicare IPO was finalised on 17 Aug 2026. You can check your allotment status using your PAN number or application number on the Purva Sharegistry (India) Private Limited portal or BSE.
The Pramodini Medicare IPO is expected to open in Aug 2026, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Pramodini Medicare IPO is ₹110.00 - ₹118.00 per share.
As per market sources, Pramodini Medicare IPO GMP is currently ₹0.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Pramodini Medicare IPO stands at 3.87x overall.
The listing date for Pramodini Medicare IPO is 19 Aug 2026.
No comments yet. Be the first to comment!
